Selskabsmeddelelse

The Stockholm County Healthcare District (SLSO) approves Ortivus as a supplier of defibrillators

The Stockholm County Healthcare District (SLSO) has approved Ortivus as a supplier of MobiMed Life, semi-automatic defibrillators, and the company has thereby qualified to become a part of the region’s framework agreement. Ortivus' solutions meet all mandatory requirements in the procurement and the customer can call-of units from qualified companies as the need arises. During the framework period, which is four years, the customer can order units to a value of maximum 2.4 MSEK.

We are pleased to announce that Ortivus has qualified for SLSO's framework agreement covering the supply of semi-automatic defibrillators to Region Stockholm’s primary care units, such as the elderly care, home care and healthcare centers. SLSO is a new customer for Ortivus, which means that the company further expands its customer base in Sweden.

The agreement refers to MobiMed Life defibrillators, Reanibex 100 and Reanibex 300. The customer will call off units from the framework agreement as need arises and actual sales can therefore not be guaranteed. Ortivus is one of several competing suppliers that have qualified for the framework agreement.

"We look forward to the possibility of delivering MobiMed Life defibrillators to primary care units across Stockholm. MobiMed Life semi-automatic defibrillators are competitive and user-friendly with innovative functionality.” Says Stefan Ekblom, Nordic Sales Manager at Ortivus.

The contract can earliest be signed after a period of 10 days from the date of the award, in accordance with the procurement regulations.

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com